SkinHealth Systems to Report Third Quarter 2026 Financial Results on November 5, 2026

By GlobeNewswire

LONG BEACH, Calif., Oct. 22, 2026 (GLOBE NEWSWIRE) -- SkinHealth Systems Inc. (NASDAQ: SKIN), a global medical aesthetics company and home to flagship brand Hydrafacial, today announced it will report third quarter 2026 financial results after market close on Thursday, November 5, 2026. The Company will host an investor conference call at 4:30 p.m. Eastern Time, following a press release detailing the results.

A live webcast of the call can be accessed on the investor relations section of the Company’s website at skinhealthsystems.com, along with supporting materials. A recording of the call will become available on the site approximately three hours after its conclusion.

Disclosure Information
SkinHealth Systems announces material information to the public through a variety of means, including filings with the Securities and Exchange Commission, press releases, public conference calls and on the investor relations section of its website (skinhealthsystems.com) as means of disclosing material non-public information and for complying with its disclosure obligations under Regulation FD.

About SkinHealth Systems
SkinHealth Systems (NASDAQ: SKIN) is a global medical aesthetics company delivering an integrated ecosystem of clinically proven solutions designed to help consumers achieve superior skin health and support the success of providers. Anchored by Hydrafacial™, a leading and widely requested professional skincare treatment, and supported by complementary offerings including SkinStylus™ microneedling and HydraScalp™ with Keravive™, SkinHealth Systems combines advanced device technology, proprietary consumables, and clinical validation to deliver trusted treatment experiences through an omnichannel network of providers worldwide. Learn more at skinhealthsystems.com or follow us on LinkedIn. Local providers can be found at hydrafacial.com/find-a-hydrafacialist.

Investors: IR@skinhealthsystems.com
Press: press@skinhealthsystems.com


Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.